Cite

HARVARD Citation

    Schwameis, M. et al. (n.d.). Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. Lancet infectious diseases. 17 (3), pp. 322-329. [Online]. 
  
Back to record